Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information.
Fierce Biotech

Harbour ships CTLA-4 asset to form new biotech in $1.1B biobucks deal

Harbour BioMed is setting sail as the Solstice begins, riding the waves of biobucks potential that could reach heights up to $1.1 billion. | Harbour BioMed is setting sail as the Solstice begins, ...
BioSpace

Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody

Solstice Oncology will gain an exclusive worldwide license to Harbour BioMed’s porustobrt, an anti-CTLA-4 antibody currently being studied for melanoma, colorectal cancer and other malignancies in ...
The Pharma Letter

Harbour BioMed strikes license deal with Solstice Oncology

Sino-US biotech Harbour BioMed has announced a license agreement and equity partnership with Solstice Oncology, a clinical ...

Wave of Chinese biotech deals builds as Harbour BioMed, Solstice sign US$1.2 billion pact

Deal involving an antibody asset 'goes beyond a traditional licensing transaction', founder and CEO says China's Harbour BioMed has struck a deal worth more than US$1.2 billion with a clinical-stage ...
Nasdaq

Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation Therapy to Address Uncontrolled Hypertension

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...

Biomed Industries Announces Phase 3 Trials of NA-931 Targeting Durable Weight Loss & Lean-Mass Preservation at JPM Week

Biomed Industries, Inc. Announces Two NA-931 Phase 3 Trials, Targeting Durable Weight Loss & Lean-Mass Preservation ...

Advanced Biomed Inc. Announces 1 for 20 Share Consolidation

Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company” or “Advanced Biomed”), a biotechnology company focused on developing and ...
The Business Journals

Texas Biomed wins designation that positions it for $100M in funding

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Heightened recognition and ...
Bisnow

BioMed To Buy South End Office Project From CIM, Nordblom, For Another Lab Pivot

BioMed Realty Trust continues to push the life sciences conversion wave in Boston, quietly taking over two prominent development sites. The Blackstone-backed life sciences investor has entered a ...
Business Wire

BioMed Realty Appoints Industry Veteran John Lee as Executive Vice President and Chief Operating Officer

SAN DIEGO--(BUSINESS WIRE)--BioMed Realty, a Blackstone portfolio company and leading provider of real estate solutions to the life science and technology industries, announced today that John Lee has ...
TMCnet

BioMed Realty's Gateway of Pacific Earns BOMA TOBY Award for Excellence in Life Science Operations

BioMed Realty, the largest private operator of real estate for the life science and technology industries, today announced that its Gateway of Pacific campus in South San Francisco has been named a ...